Guardant Health, Inc. (GH) Selling and Marketing Expense USD 2017 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary: Guardant Health, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2017 to 2024.
Guardant Health, Inc. Selling and Marketing Expense for the quarter ending March 31, 2024 was $80.4 M, a 5.65% increase year-over-year.
Guardant Health, Inc. Selling and Marketing Expense for the twelve months ending March 31, 2024 was $300 M, a 3.85% decline year-over-year.
Guardant Health, Inc. annual Selling and Marketing Expense for 2023 was $295 M, a 1.54% decline from 2022.
Guardant Health, Inc. annual Selling and Marketing Expense for 2022 was $300 M, a 56.3% increase from 2021.
Guardant Health, Inc. annual Selling and Marketing Expense for 2021 was $192 M, a 80.1% increase from 2020.

Selling and Marketing Expense, Trailing 12 Months (USD)

Selling and Marketing Expense, Quarterly (USD)

Selling and Marketing Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$300 M	$80.4 M	+$4.3 M	+5.65%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$295 M	$79.1 M	-$2.3 M	-2.82%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	$298 M	$68.9 M	-$11.4 M	-14.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$309 M	$71 M	-$2.56 M	-3.48%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$312 M	$76.1 M	+$11.7 M	+18.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$300 M	$81.4 M	+$21.8 M	+36.6%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$278 M	$80.4 M	+$30.1 M	+60%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-06
Q2 2022	$248 M	$73.6 M	+$25.9 M	+54.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$222 M	$64.4 M	+$30.1 M	+87.6%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$192 M	$59.6 M	+$28.3 M	+90.5%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-22
Q3 2021	$164 M	$50.2 M	+$25.1 M	+100%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$138 M	$47.7 M	+$22.7 M	+90.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$116 M	$34.3 M	+$9.22 M	+36.7%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$107 M	$31.3 M	+$9 M	+40.4%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-23
Q3 2020	$97.5 M	$25.1 M	+$6.29 M	+33.5%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$91.2 M	$25 M	+$5.58 M	+28.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$85.6 M	$25.1 M	+$7.31 M	+41%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$78.3 M	$22.3 M	+$5.17 M	+30.2%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-24
Q3 2019	$73.2 M	$18.8 M	+$5.34 M	+39.6%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$67.8 M	$19.4 M	+$7.86 M	+67.9%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$60 M	$17.8 M	+$6.5 M	+57.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$53.5 M	$17.1 M			Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018		$13.5 M	+$5.66 M	+72.4%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		$11.6 M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018		$11.3 M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q3 2017		$7.81 M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.